BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33761441)

  • 1. Thermal ablation of medium-sized hepatocellular carcinomas using intraoperative ultrasound fusion imaging: A propensity score-matched analysis.
    Luo L; He X; Li K; Long Y; Zeng Q; Tan L; Zheng R; Xu E
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101581. PubMed ID: 33761441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.
    An C; Li WZ; Huang ZM; Yu XL; Han YZ; Liu FY; Wu SS; Yu J; Liang P; Huang J
    Eur Radiol; 2021 Jul; 31(7):4764-4773. PubMed ID: 33399908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K; Seki T; Aoi K; Yamashina M; Murata M; Yamashiki N; Nishio A; Shimatani M; Naganuma M
    Abdom Radiol (NY); 2021 Aug; 46(8):3790-3797. PubMed ID: 33675382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis.
    Feng Y; Wang L; Lv H; Shi T; Xu C; Zheng H; Qi J; Zhao X; Li J; Gao Y; Qin C; Zhu Q
    HPB (Oxford); 2021 Apr; 23(4):512-519. PubMed ID: 32839089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes.
    Hu H; Chi JC; Liu R; Zhai B
    Int J Hyperthermia; 2021; 38(1):191-201. PubMed ID: 33682598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score-matched study.
    Zheng H; Liu K; Yang Y; Liu B; Zhao X; Chen Y; Feng Y; Meng M; Tan X; Zhu Q
    Eur Radiol; 2022 Jul; 32(7):4657-4666. PubMed ID: 35092477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes.
    Song KD; Lee MW; Rhim H; Kang TW; Cha DI; Sinn DH; Lim HK
    Radiology; 2018 Sep; 288(3):878-886. PubMed ID: 29916771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined transarterial chemoembolization and radiofrequency ablation for small treatment-naïve hepatocellular carcinoma infeasible for ultrasound-guided radiofrequency ablation: long-term outcomes.
    Hyun D; Cho SK; Shin SW; Park KB; Lee SY; Park HS; Do YS
    Acta Radiol; 2018 Jul; 59(7):773-781. PubMed ID: 29034691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency ablation combined with chemoembolization for intermediate-sized (3-5 cm) hepatocellular carcinomas under dual guidance of biplane fluoroscopy and ultrasonography.
    Min JH; Lee MW; Cha DI; Jeon YH; Shin SW; Cho SK; Rhim H; Lim HK
    Korean J Radiol; 2013; 14(2):248-58. PubMed ID: 23483753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S; Shi M; Shen L; Qi H; Wan W; Cao F; Xie L; Wu Y; Chen G; Mo J; Zhu G; Ye D; Zhang Y; Feng Z; Xu L; Fan W
    Int J Hyperthermia; 2020; 37(1):384-391. PubMed ID: 32323585
    [No Abstract]   [Full Text] [Related]  

  • 13. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study.
    Yao J; Liu B; Wang X; Yu J; Cheng Z; Han Z; Liu F; Zheng R; Cheng W; Wei Q; Yu S; Li K; Chen P; Luo Y; Yu X; Liang P
    Int J Hyperthermia; 2022; 39(1):209-216. PubMed ID: 35067144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microwave ablation versus radiofrequency ablation as bridge therapy in potentially transplantable patients with single HCC ≤ 3 cm: A propensity score-matched study.
    Wang X; Yu H; Zhao F; Xu Y; Wang C; Liu K; Liu B; Zheng H; Wei Y; Wang X; Zhu Q; Huang M; Feng Y
    Eur J Radiol; 2023 Jul; 164():110860. PubMed ID: 37178491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Small Hepatocellular Carcinoma (≤2 cm) in the Caudate Lobe with Sequential Transcatheter Arterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Rhim H; Koh KC; Paik SW
    Cardiovasc Intervent Radiol; 2016 Jul; 39(7):1015-22. PubMed ID: 26975761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Therapy of Transcatheter Arterial Chemoembolization and Radiofrequency Ablation versus Surgical Resection for Single 2-3 cm Hepatocellular Carcinoma: A Propensity-Score Matching Analysis.
    Lee HJ; Kim JW; Hur YH; Shin SS; Heo SH; Cho SB; Kang YJ; Lim HS; Seon HJ; Jeong YY
    J Vasc Interv Radiol; 2017 Sep; 28(9):1240-1247.e3. PubMed ID: 28688816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching monopolar radiofrequency ablation improves long-term outcomes of medium-sized hepatocellular carcinoma.
    Lin CC; Lui KW; Chen WT; Hsieh YC; Cheng YT; Teng W; Lin SM
    Eur Radiol; 2021 Nov; 31(11):8649-8661. PubMed ID: 33895858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas.
    Zheng L; Li HL; Guo CY; Luo SX
    Korean J Radiol; 2018; 19(2):237-246. PubMed ID: 29520181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography.
    Park HJ; Lee MW; Rhim H; Cha DI; Kang TW; Lim S; Song KD; Lim HK
    Clin Radiol; 2015 Apr; 70(4):387-94. PubMed ID: 25582889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.